Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
Heliyon
|
March 8, 2021
Epigallocatechin 3-gallate inhibits the plasma membrane Ca<sup>2+</sup>-ATPase: effects on calcium homeostasis
Débora E Rinaldi, Mallku Q Ontiveros, Nicolas A Saffioti, et al.
Chemistry & Biodiversity
|
October 5, 2023
N-Sulfonyl-1,2,3,4-tetrahydroisoquinoline Derivatives: Synthesis, Antimicrobial Evaluations, and Theoretical Insights
Martín E Rinaldi Tosi, Valeria Palermo, Fernando A Giannini, et al.
International Journal of Oncology
|
May 12, 2011
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma
A Riccardi, G Ucci, S Brugnatelli, et al.
British Journal of Cancer
|
March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma
S Brugnatelli, A Riccardi, G Ucci, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
July 3, 2021
Extracellular ATP hydrolysis in Caco-2 human intestinal cell line
J Schachter, C L Alvarez, Z Bazzi, et al.
Physical Review Letters
|
November 10, 2018
Heavy Physics Contributions to Neutrinoless Double Beta Decay from QCD
A Nicholson, E Berkowitz, H Monge-Camacho, et al.
Tumori
|
December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer
A Riccardi, S Brugnatelli, M Giordano, et al.
British Journal of Cancer
|
February 7, 2001
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma
A Riccardi, O Mora, C Tinelli, et al.
British Journal of Cancer
|
February 24, 1998
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma
A Riccardi, O Mora, S Brugnatelli, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
Heliyon
|
March 8, 2021
Epigallocatechin 3-gallate inhibits the plasma membrane Ca<sup>2+</sup>-ATPase: effects on calcium homeostasis
Débora E Rinaldi, Mallku Q Ontiveros, Nicolas A Saffioti, et al.
Chemistry & Biodiversity
|
October 5, 2023
N-Sulfonyl-1,2,3,4-tetrahydroisoquinoline Derivatives: Synthesis, Antimicrobial Evaluations, and Theoretical Insights
Martín E Rinaldi Tosi, Valeria Palermo, Fernando A Giannini, et al.
International Journal of Oncology
|
May 12, 2011
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma
A Riccardi, G Ucci, S Brugnatelli, et al.
British Journal of Cancer
|
March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma
S Brugnatelli, A Riccardi, G Ucci, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
July 3, 2021
Extracellular ATP hydrolysis in Caco-2 human intestinal cell line
J Schachter, C L Alvarez, Z Bazzi, et al.
Physical Review Letters
|
November 10, 2018
Heavy Physics Contributions to Neutrinoless Double Beta Decay from QCD
A Nicholson, E Berkowitz, H Monge-Camacho, et al.
Tumori
|
December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer
A Riccardi, S Brugnatelli, M Giordano, et al.
British Journal of Cancer
|
February 7, 2001
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma
A Riccardi, O Mora, C Tinelli, et al.
British Journal of Cancer
|
February 24, 1998
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma
A Riccardi, O Mora, S Brugnatelli, et al.
Page
of 18